Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis.

Sakkas LI, Zafiriou E, Bogdanos DP.

Front Pharmacol. 2019 Aug 6;10:872. doi: 10.3389/fphar.2019.00872. eCollection 2019. Review.

2.

On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells.

Ntolkeras G, Barba C, Mavropoulos A, Vasileiadis GK, Dardiotis E, Sakkas LI, Hadjigeorgiou G, Bogdanos DP.

Immunol Res. 2019 Aug 9. doi: 10.1007/s12026-019-09089-5. [Epub ahead of print] Review.

PMID:
31399952
3.

A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis.

Efthymiou G, Dardiotis E, Liaskos C, Marou E, Scheper T, Meyer W, Daponte A, Daoussis D, Hadjigeorgiou G, Bogdanos DP, Sakkas LI.

Clin Immunol. 2019 Oct;207:87-96. doi: 10.1016/j.clim.2019.07.012. Epub 2019 Jul 29.

PMID:
31369821
4.

Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis.

Mavropoulos A, Zafiriou E, Simopoulou T, Brotis AG, Liaskos C, Roussaki-Schulze A, Katsiari CG, Bogdanos DP, Sakkas LI.

Rheumatology (Oxford). 2019 Dec 1;58(12):2240-2250. doi: 10.1093/rheumatology/kez204.

PMID:
31209492
5.

The Second Greek-Israeli Symposium on Autoimmunity and Rheumatology: Success Through Synergy.

Sakkas LI, Bogdanos DP, Boumpas D, Mamouris Z, Gkoutzourelas A, Mavropoulos A, Tsouris Z, Liossis SN, Daoussis D, Vasilopoulos D, Tektonidou M, Tzioufas A, Efthymiou G, Dardiotis E, Kitas G, Sharif Κ, Blank M, Karussis D, Rimar D, Slobodin G, Porat-Katz BS, Vadasz Z, Amital H, Toubi E, Shoenfeld Y.

Isr Med Assoc J. 2019 Apr;21(4):292-297. No abstract available.

6.

The Greek (Hellenic) rheumatology over the years: from ancient to modern times.

Sakkas LI, Tronzas P.

Rheumatol Int. 2019 Jun;39(6):947-955. doi: 10.1007/s00296-019-04261-4. Epub 2019 Feb 25.

PMID:
30805680
7.

Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.

Gkoutzourelas A, Liaskos C, Mytilinaiou MG, Simopoulou T, Katsiari C, Tsirogianni A, Daoussis D, Scheper T, Meyer W, Bogdanos DP, Sakkas LI.

Front Immunol. 2018 Dec 7;9:2835. doi: 10.3389/fimmu.2018.02835. eCollection 2018.

8.

Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?

Vasileiadis GK, Dardiotis E, Mavropoulos A, Tsouris Z, Tsimourtou V, Bogdanos DP, Sakkas LI, Hadjigeorgiou GM.

Auto Immun Highlights. 2018 Nov 10;9(1):9. doi: 10.1007/s13317-018-0109-x. Review.

9.

Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases.

Sakkas LI, Daoussis D, Mavropoulos A, Liossis SN, Bogdanos DP.

Semin Arthritis Rheum. 2019 Jun;48(6):1133-1141. doi: 10.1016/j.semarthrit.2018.10.007. Epub 2018 Oct 15. Review.

PMID:
30409417
10.

Curcumin for the Management of Periodontitis and Early ACPA-Positive Rheumatoid Arthritis: Killing Two Birds with One Stone.

Asteriou E, Gkoutzourelas A, Mavropoulos A, Katsiari C, Sakkas LI, Bogdanos DP.

Nutrients. 2018 Jul 16;10(7). pii: E908. doi: 10.3390/nu10070908. Review.

11.

Immunotherapy of systemic sclerosis.

Katsiari CG, Simopoulou T, Alexiou I, Sakkas LI.

Hum Vaccin Immunother. 2018;14(11):2559-2567. doi: 10.1080/21645515.2018.1491508. Epub 2018 Jul 16.

12.

IL-35: a new immunomodulator in autoimmune rheumatic diseases.

Sakkas LI, Mavropoulos A, Perricone C, Bogdanos DP.

Immunol Res. 2018 Jun;66(3):305-312. doi: 10.1007/s12026-018-8998-3. Review.

PMID:
29749583
13.

The Role of Flavonoids in Inhibiting Th17 Responses in Inflammatory Arthritis.

Kelepouri D, Mavropoulos A, Bogdanos DP, Sakkas LI.

J Immunol Res. 2018 Mar 5;2018:9324357. doi: 10.1155/2018/9324357. eCollection 2018. Review.

14.

Multiple hit infection and autoimmunity: the dysbiotic microbiota-ACPA connection in rheumatoid arthritis.

Sakkas LI, Bogdanos DP.

Curr Opin Rheumatol. 2018 Jul;30(4):403-409. doi: 10.1097/BOR.0000000000000503. Review.

PMID:
29538012
15.

Intestinal Involvement in Systemic Sclerosis: A Clinical Review.

Sakkas LI, Simopoulou T, Daoussis D, Liossis SN, Potamianos S.

Dig Dis Sci. 2018 Apr;63(4):834-844. doi: 10.1007/s10620-018-4977-8. Epub 2018 Feb 21. Review.

PMID:
29464583
16.

The Infectious Basis of ACPA-Positive Rheumatoid Arthritis.

Sakkas LI, Daoussis D, Liossis SN, Bogdanos DP.

Front Microbiol. 2017 Sep 27;8:1853. doi: 10.3389/fmicb.2017.01853. eCollection 2017. Review.

17.

Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis.

Efthymiou G, Dardiotis E, Liaskos C, Marou E, Tsimourtou V, Rigopoulou EI, Scheper T, Daponte A, Meyer W, Sakkas LI, Hadjigeorgiou G, Bogdanos DP.

Sci Rep. 2017 Aug 11;7(1):7929. doi: 10.1038/s41598-017-07801-9.

18.

Disease-related autoantibody profile in patients with systemic sclerosis.

Liaskos C, Marou E, Simopoulou T, Barmakoudi M, Efthymiou G, Scheper T, Meyer W, Bogdanos DP, Sakkas LI.

Autoimmunity. 2017 Nov;50(7):414-421. doi: 10.1080/08916934.2017.1357699. Epub 2017 Jul 27.

PMID:
28749191
19.

Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives.

Sakkas LI, Mavropoulos A, Bogdanos DP.

Curr Med Chem. 2017;24(28):3054-3067. doi: 10.2174/0929867324666170530093902. Review.

PMID:
28554321
20.

IL-10-producing regulatory B cells (B10 cells), IL-17+ T cells and autoantibodies in systemic sclerosis.

Mavropoulos A, Liaskos C, Simopoulou T, Bogdanos DP, Sakkas LI.

Clin Immunol. 2017 Nov;184:26-32. doi: 10.1016/j.clim.2017.04.013. Epub 2017 May 11.

PMID:
28502678

Supplemental Content

Loading ...
Support Center